Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
University of Colorado, Denver · NCT03797183
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 0 mo–40 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 90
- US sites recruiting
- 1
- Study start
- May 3, 2019
- Record last updated
- November 13, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to evaluate the Genesis Electrical Impedance Tomography (EIT) imaging system for use in pediatric respiratory disease populations including neuromuscular and bronchopulmonary dysplasia, as well as in age and height matched controls. The EIT does not use radiation, and is read through electrodes.
Conditions: Premature Infant; Chronic Respiratory Disease; Neuromuscular Diseases; Healthy; Bronchopulmonary Dysplasia; Pulmonary Vein Stenoses
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 2 weeks old - 40 years old
- Premature infants with current age >2 weeks with a confirmed diagnosis of BPD based on NIH criteria
- Or Chronic respiratory disease due to underlying neuromuscular disease
- Or confirmed neuromuscular disease with an echo completed within the preceding 12 months of study participation of DMD or other diagnoses associated with mild cardiomyopathy.
- have had a VQ scan
- will be undergoing cardiac catherization for for pulmonary vein stenosis, pulmonary hypertension and/or pulmonary artery stenosis
- Or healthy controls
Exclusion Criteria
- \<2 weeks of age
- Congenital diaphragmatic hernia
- Severe congenital heart disease
- Significant genetic abnoralities
- Anything that interferes with lead placement on the chest wall
- Unwilling/refusal to sign consent
- Pregnant or lactating
- Pacemaker of other surgical implant and spinal implant (causes noise in the data)
- Moderate to severe cardiomyopathy
- Patients with temporary cognitive disability due to illness
Recruiting US locations
Children's Hospital Colorado
Aurora, CO 80045
Site contact: Emily DeBoer, MD · 720-777-4953 · emily.deboer@childrenscolorado.org
Study contacts (from the official record)
- Emily DeBoer, MD · 720-777-4953 · emily.deboer@childrenscolorado.org
Similar studies in Colorado
All healthy volunteers studies in Colorado →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Aurora, CO + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Aurora, CO + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Aurora, CO + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Aurora, CO + 18 other US sites
- Eligibility basics
- Ages 18–100